Stay updated on Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.

Latest updates to the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision v3.5.0 was added to the history and v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedAdded a history entry for Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check54 days agoChange DetectedA new Revision: v3.4.2 was added to the record history, and the previously listed notices for funding lapsed (Revision: v3.4.1) were removed.SummaryDifference0.5%

- Check61 days agoChange DetectedNotice about government funding and NIH Clinical Center status is displayed, and the page shows revision v3.4.1 replacing v3.4.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check68 days agoChange DetectedThe page now includes a glossary toggle and green/red color-coding for additions and deletions in the revision history, and the revision label updated to v3.4.0.SummaryDifference0.6%

- Check82 days agoChange DetectedRevision: v3.3.4 was added to the page history, replacing the previous v3.3.3 entry.SummaryDifference0.1%

Stay in the know with updates to Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.